Search Results for "En Vivo EVP6124 Alzheimer"

07:27 EST 8th February 2016 | BioPortfolio

Matching Channels

Cytoplasmic Protein Tau

One of the main pillars of current drug discovery and development activities in the pharmaceutical industry for Alzheimer's disease is prevention of the accumulation of misfolded proteins, i.e. ...

Histone Deacetylase HDAC Inhibitors

Histone deacetylase (HDAC) inhibitors are emerging as a new class of potential anticancer agents for the treatment of solid and hematological malignancies. HDAC inhibition causes acetylated nuclear ...

Nerve growth factor NGF

Nerve growth factor (NGF) is the prototypical member of the family of neurotrophin growth factors that are involved in the growth and survival of nervous tissue. NGF and its receptors, the tyrosine-...

Interleukin 1 IL 1 Receptor IL 1R

Interleukin-1 (IL-1) beta is a proinflammatory cytokine driving joint inflammation as well as systemic signs of inflammation, such as fever and acute phase protein production. Current therapy targetin...

Selective monoamine oxidase type B MAOB inhibitors

The clinical benefit of monoamine oxidase type B (MAO-B) inhibitors is thought to arise from an ability of these medications to enhance the level of dopamine by decreasing the catabolism. Additional...

Matching News

Potential Saliva Test to Detect Alzheimer’s

Saliva may be a new, easily-accessible, avenue for Alzheimer’s detection. A small study, presented at the 2015 Alzheimer’s Association International Conference in Washington, D.C this week, showe...

N.J. Researchers Closing in on Alzheimer’s, Parkinson’s Tests

Alzheimer’s is feared for its quiet progress, giving only overlooked warning signs until it’s too late to use the few interventions available to slow it down. But a new test under development at ...

Physical exercise could help curb symptoms of Alzheimer's

Three studies (American, Danish and Canadian), presented simultaneously at the Alzheimer's Association International Conference (AAIC), indicate that physical exercise may help people live better...

Biopharmaceutical industry is essential to development of Alzheimer’s treatments

This week, presidential candidate Hillary Clinton called for a spending increase by the federal government to find a cure to the costly and devastating Alzheimer’s disease. Finding a bet...

A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome

Individuals with Down syndrome have an enhanced risk of developing early onset Alzheimer disease. Here, the authors describe the features of Alzheimer disease in Down syndrome and show how understandi...

Breakthrough Prize for Alzheimer’s Disease 2016

Breakthrough Prize for Alzheimer’s Disease 2016 Larry H. Bernstein, MD, FCAP, Curator LPBI   Breakthrough Prize given for Alzheimer’s research By Tim Sandle     http://www.digitalj...

Brains of CJD victims show signs of Alzheimer’s pathology

Victims of Creutzfeldt–Jakob disease show evidence of Alzheimer’s pathology, suggests new research. But neuroscientists have quashed fears that people can “catch” Alzheimer’s.

Researchers Study Alzheimer’s Disease in People with Down Syndrome

The risk of Alzheimer’s disease—the most common cause of dementia—increases as a person ages. But the risk of Alzheimer’s is increased dramatically for adults with Down syndrome.Read more a

Matching PubMed Articles

Search Whole site using Google

Quick Search
Advertisement Advertisement